+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Discovery AI"

From
From
From
From
From
AI in Pharmacovigilance Training Course (November 19, 2025) - Product Thumbnail Image

AI in Pharmacovigilance Training Course (November 19, 2025)

  • Conference
  • November 2025
  • 1 Day
  • Global
AI in Pharmacovigilance Training Course (July 7, 2025) - Product Thumbnail Image

AI in Pharmacovigilance Training Course (July 7, 2025)

  • Conference
  • July 2025
  • 1 Day
  • Global
Generative AI in Drug Discovery (Recorded) - Product Thumbnail Image

Generative AI in Drug Discovery (Recorded)

  • Training
  • April 2025
  • 1 Day
  • Global
From
From
AI in Bio Pharmaceuticals - Product Thumbnail Image

AI in Bio Pharmaceuticals

  • Report
  • April 2022
  • Global
Loading Indicator

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery. The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more